Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study
在 HIV 感染儿童中，分散片和速释片阿巴卡韦、多替拉韦和拉米夫定的药代动力学、安全性和耐受性（IMPAACT 2019）：一项开放标签、多中心、1/2 期剂量确认研究的第 24 周结果
期刊:Lancet HIV
影响因子:13
doi:10.1016/S2352-3018(23)00107-8
Brooks, Kristina M; Kiser, Jennifer J; Ziemba, Lauren; Ward, Shawn; Rani, Yasha; Cressey, Tim R; Masheto, Gaerolwe R; Cassim, Haseena; Deville, Jaime G; Ponatshego, Ponego L; Patel, Faeezah; Aurpibul, Linda; Barnabas, Shaun L; Mustich, Iris; Coletti, Anne; Heckman, Barbara; Krotje, Chelsea; Lojacono, Mark; Yin, Dwight E; Townley, Ellen; Moye, Jack; Majji, Sai; Acosta, Edward P; Ryan, Kevin; Chandasana, Hardik; Brothers, Cynthia H; Buchanan, Ann M; Rabie, Helena; Flynn, Patricia M
